301 related articles for article (PubMed ID: 22699851)
1. Metals, membranes, and amyloid-β oligomers: key pieces in the Alzheimer's disease puzzle?
Watt AD; Villemagne VL; Barnham KJ
J Alzheimers Dis; 2013; 33 Suppl 1():S283-93. PubMed ID: 22699851
[TBL] [Abstract][Full Text] [Related]
2. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
Drew SC; Barnham KJ
Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
[TBL] [Abstract][Full Text] [Related]
3. Synaptotoxic amyloid-β oligomers: a molecular basis for the cause, diagnosis, and treatment of Alzheimer's disease?
Klein WL
J Alzheimers Dis; 2013; 33 Suppl 1():S49-65. PubMed ID: 22785404
[TBL] [Abstract][Full Text] [Related]
4. The use of mass spectrometry to study amyloid-β peptides.
Grasso G
Mass Spectrom Rev; 2011; 30(3):347-65. PubMed ID: 21500241
[TBL] [Abstract][Full Text] [Related]
5. Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity.
Tõugu V; Tiiman A; Palumaa P
Metallomics; 2011 Mar; 3(3):250-61. PubMed ID: 21359283
[TBL] [Abstract][Full Text] [Related]
6. Cu(II) interaction with amyloid-beta peptide: a review of neuroactive mechanisms in AD brains.
Lin CJ; Huang HC; Jiang ZF
Brain Res Bull; 2010 Jul; 82(5-6):235-42. PubMed ID: 20598459
[TBL] [Abstract][Full Text] [Related]
7. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis.
Castello MA; Soriano S
Ageing Res Rev; 2014 Jan; 13():10-2. PubMed ID: 24252390
[TBL] [Abstract][Full Text] [Related]
8. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
Tomiyama T
Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
[TBL] [Abstract][Full Text] [Related]
9. Understanding the cause of sporadic Alzheimer's disease.
Zetterberg H; Mattsson N
Expert Rev Neurother; 2014 Jun; 14(6):621-30. PubMed ID: 24852227
[TBL] [Abstract][Full Text] [Related]
10. Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation.
Zheng W; Xin N; Chi ZH; Zhao BL; Zhang J; Li JY; Wang ZY
FASEB J; 2009 Dec; 23(12):4207-17. PubMed ID: 19679638
[TBL] [Abstract][Full Text] [Related]
11. Limited expression of heparan sulphate proteoglycans associated with Aβ deposits in the APPswe/PS1dE9 mouse model for Alzheimer's disease.
Timmer NM; Herbert MK; Kleinovink JW; Kiliaan AJ; De Waal RM; Verbeek MM
Neuropathol Appl Neurobiol; 2010 Oct; 36(6):478-86. PubMed ID: 20831743
[TBL] [Abstract][Full Text] [Related]
12. Sink hypothesis and therapeutic strategies for attenuating Abeta levels.
Zhang Y; Lee DH
Neuroscientist; 2011 Apr; 17(2):163-73. PubMed ID: 21330304
[TBL] [Abstract][Full Text] [Related]
13. The molecular pathology of Alzheimer's disease.
Harrington CR
Neuroimaging Clin N Am; 2012 Feb; 22(1):11-22, vii. PubMed ID: 22284730
[TBL] [Abstract][Full Text] [Related]
14. Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity.
Bolognin S; Messori L; Drago D; Gabbiani C; Cendron L; Zatta P
Int J Biochem Cell Biol; 2011 Jun; 43(6):877-85. PubMed ID: 21376832
[TBL] [Abstract][Full Text] [Related]
15. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients.
Li R; Lindholm K; Yang LB; Yue X; Citron M; Yan R; Beach T; Sue L; Sabbagh M; Cai H; Wong P; Price D; Shen Y
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3632-7. PubMed ID: 14978286
[TBL] [Abstract][Full Text] [Related]
16. Pyroglutamate-Aβ: role in the natural history of Alzheimer's disease.
Gunn AP; Masters CL; Cherny RA
Int J Biochem Cell Biol; 2010 Dec; 42(12):1915-8. PubMed ID: 20833262
[TBL] [Abstract][Full Text] [Related]
17. Elucidating the role of metals in Alzheimer's disease through the use of Surface-Enhanced Laser Desorption/Ionisation time-of-flight mass spectrometry.
Watt AD; Perez KA; Hung LW
Methods Mol Biol; 2011; 752():229-40. PubMed ID: 21713641
[TBL] [Abstract][Full Text] [Related]
18. Oligomers, fact or artefact? SDS-PAGE induces dimerization of β-amyloid in human brain samples.
Watt AD; Perez KA; Rembach A; Sherrat NA; Hung LW; Johanssen T; McLean CA; Kok WM; Hutton CA; Fodero-Tavoletti M; Masters CL; Villemagne VL; Barnham KJ
Acta Neuropathol; 2013 Apr; 125(4):549-64. PubMed ID: 23354835
[TBL] [Abstract][Full Text] [Related]
19. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization.
De Felice FG; Vieira MN; Saraiva LM; Figueroa-Villar JD; Garcia-Abreu J; Liu R; Chang L; Klein WL; Ferreira ST
FASEB J; 2004 Sep; 18(12):1366-72. PubMed ID: 15333579
[TBL] [Abstract][Full Text] [Related]
20. Copper(I) and copper(II) inhibit Aβ peptides proteolysis by insulin-degrading enzyme differently: implications for metallostasis alteration in Alzheimer's disease.
Grasso G; Pietropaolo A; Spoto G; Pappalardo G; Tundo GR; Ciaccio C; Coletta M; Rizzarelli E
Chemistry; 2011 Feb; 17(9):2752-62. PubMed ID: 21274957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]